Our data indicated significant downregulation of CDK4 and CDK6 and marked activation of PARP and caspase-3 after silencing of PSMD3 in BT-474, SKBR3, and HCC-1419 cells. This evidence concerns the gene CDK4 and hepatocellular carcinoma.